Gilead Sciences Ownership | Who Owns Gilead Sciences?


OverviewForecastRevenueFinancialsChartTranscripts

Gilead Sciences Ownership Summary


Gilead Sciences is owned by 82.38% institutional investors, 0.12% insiders, and 17.49% retail investors. Vanguard group is the largest institutional shareholder, holding 9.74% of GILD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.19% of its assets in Gilead Sciences shares.

GILD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGilead Sciences82.38%0.12%17.49%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryDrug Manufacturers - General Stocks45.52%6.03%48.45%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group121.10M9.74%$14.86B
Blackrock120.63M9.67%$8.28B
Blackrock funding, inc. /de119.01M9.57%$16.59B
Fmr71.91M5.78%$10.02B
State street59.86M4.81%$8.34B
Capital world investors41.28M3.32%$5.75B
Jpmorgan chase33.99M2.73%$4.63B
Geode capital management29.73M2.39%$4.14B
Capital research global investors27.13M2.18%$3.78B
Price t rowe associates inc /md/26.25M2.11%$3.66B

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mccarthy asset management130.36K5.27%$8.94M
Nexus investment management ulc254.72K4.96%$35.50M
Catalio capital management, lp163.91K4.77%$22.84M
Opes wealth management169.65K3.89%$23.64M
Bellevue group1.17M3.88%$163.05M
Kiltearn partners llp100.40K3.76%$13.99M
Sectoral asset management27.49K3.42%$4.13M
Kessler investment group49.80K3.29%$6.94M
Twin lakes capital management58.75K3.20%$7.21M
Nia impact advisors49.64K3.08%$6.92M

Top Buyers

HolderShares% AssetsChange
Norges bank21.32M0.28%21.32M
Jpmorgan chase33.99M0.30%10.96M
Vanguard fiduciary trust7.03M0.25%7.03M
Fmr71.91M0.53%6.33M
Vanguard global advisers2.77M0.21%2.77M

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de119.01M0.29%-4.18M
Barclays5.28M0.18%-3.83M
Pacer advisors---3.38M
Los angeles capital management73.46K0.04%-3.10M
Amundi7.58M0.28%-2.88M

New Positions

HolderShares% AssetsChangeValue
Norges bank21.32M0.28%21.32M$2.62B
Vanguard fiduciary trust7.03M0.25%7.03M$980.15M
Vanguard global advisers2.77M0.21%2.77M$385.82M
Vanguard asset management2.50M0.30%2.50M$348.95M
Axa investment managers1.66M0.50%1.66M$184.10M

Sold Out

HolderChange
Hoey investments-2.00
Mendota financial group-3.00
Breakwater investment management-4.00
Cypress capital management llc (wy)-5.00
New millennium group-7.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20262,3201.67%1,024,836,704-6.01%821.07%1,070-11.13%86616.71%
Dec 31, 20251,572-24.82%596,256,840-43.48%470.67%840-15.07%515-28.57%
Sep 30, 20251,457-29.51%484,334,760-52.85%380.57%702-30.56%504-30.86%
Jun 30, 20252,053-0.73%1,072,004,9014.47%861.27%1,0044.26%720-12.41%
Mar 31, 202519-99.01%5,280,450-99.50%-0.01%7-99.24%5-99.30%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv39.56M3.19%115.58K
Vanguard US Total Market Shares ETF39.45M3.17%28.77K
Vanguard Institutional 500 Index Trust35.44M2.85%245.78K
Vanguard 500 Index Investor32.17M2.59%577.70K
Invesco QQQ Trust26.57M2.14%195.46K
Dodge & Cox Stock I18.09M1.46%-1.41M
iShares Core S&P 500 ETF16.05M1.29%47.06K
Fidelity 500 Index15.84M1.28%55.23K
American Funds Income Fund of Amer A15.50M1.25%-4.12M
SPDR® S&P 500 ETF15.51M1.25%-227.69K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 01, 2026O'Day Daniel Patrick Chairman & CEOSell$1.43M
Jun 01, 2026O'Day Daniel Patrick Chairman & CEOSell$138.02K
Jun 01, 2026O'Day Daniel Patrick Chairman & CEOSell$404.84K
May 15, 2026Dickinson Andrew D Chief Financial OfficerSell$396.81K
May 15, 2026Mercier Johanna Chief Comm & Corp Aff OfficerSell$1.11M

Insider Transactions Trends


DateBuySell
2026 Q2-12
2026 Q1-17
2025 Q4-18
2025 Q3-16
2025 Q2-11

GILD Ownership FAQ


Who Owns Gilead Sciences?

Gilead Sciences shareholders are primarily institutional investors at 82.38%, followed by 0.12% insiders and 17.50% retail investors. The average institutional ownership in Gilead Sciences's industry, Drug Manufacturers - General Stocks, is 45.52%, which Gilead Sciences exceeds.

Who owns the most shares of Gilead Sciences?

Gilead Sciences’s largest shareholders are Vanguard group (121.1M shares, 9.74%), Blackrock (120.63M shares, 9.67%), and Blackrock funding, inc. /de (119.01M shares, 9.57%). Together, they hold 28.98% of Gilead Sciences’s total shares outstanding.

Does Blackrock own Gilead Sciences?

Yes, BlackRock owns 9.67% of Gilead Sciences, totaling 120.63M shares as of Jun 2024. This represents 0.19% of BlackRock's total assets, with a market value of 8.28B$. In the last quarter, BlackRock decreased its holdings by -1.899M shares, a -1.55% change.

Who is Gilead Sciences’s biggest shareholder by percentage of total assets invested?

Mccarthy asset management is Gilead Sciences’s biggest shareholder by percentage of total assets invested, with 5.27% of its assets in 130.36K Gilead Sciences shares, valued at 8.94M$.

Who is the top mutual fund holder of Gilead Sciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Gilead Sciences shares, with 3.19% of its total shares outstanding invested in 39.56M Gilead Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools